Tumor Biology

, Volume 37, Issue 12, pp 15997–16004 | Cite as

Highly expressed lncRNA CRNDE promotes cell proliferation through Wnt/β-catenin signaling in renal cell carcinoma

  • Kun Shao
  • Tianming Shi
  • Yang Yang
  • Xianghui Wang
  • Da Xu
  • Peijun Zhou
Original Article


Recently, numerous studies revealed that long non-coding RNAs (lncRNAs) play complex roles in the field of tumor biology, while the functions of lncRNA in renal cell carcinoma (RCC) remain largely unknown. In the current study, we retrieved Oncomine database and found a lncRNA colorectal neoplasia differentially expressed (CRNDE) which is highly expressed in different cohorts of RCC patients; this clue reminds us that CRNDE might exert its functions in RCC tumorigenesis. We then detected the level of CRNDE in fresh RCC tissues and found that CRNDE is significantly up-regulated compared with adjacent tissues. Furthermore, both loss and gain function assays revealed that CRNDE promotes RCC cell proliferation and growth both in vitro and in vivo.

In addition, we found that CRNDE regulates the cell cycle transition from G0/G1 stage to S stage and modulates the expression of CCND1 and CCNE1. Moreover, we further illustrated that CRNDE activates Wnt/β-catenin signaling in RCC cell lines. Taken together, in the current study, we found that lncRNA CRNDE is highly expressed in RCC malignant tissues and the heightened CRNDE robustly promotes RCC cell proliferation through activating Wnt/β-catenin signaling; our findings enlarge our knowledge in the molecular pathology of RCC tumorigenesis.


CRNDE Cell proliferation Wnt/β-catenin signaling Renal cell carcinoma 



We thank Dr. He’s for the constructive suggestions in the experiment design and the preparation of the manuscript.

Compliance with ethical standards

Conflicts of interest


Supplementary material

13277_2016_5440_Fig7_ESM.jpg (175 kb)
Figure 1S

(A) The expression of CRNDE is significantly down-regulated in 786-O and A498 cell lines. (B) Overexpression of CRNDE dramatically elevates the expression of CRNDE in HEK-293T cell lines (JPEG 174 kb)

13277_2016_5440_Fig8_ESM.jpg (68 kb)
Figure 2S

3X Flag tagged CRNDE validated the non-coding potential of CRNDE. Western blots shown that CRNDE and positive control UCA1 could not be determined by Flag antibody, while negatively control LKB1 could be examined (JPEG 68 kb)


  1. 1.
    Gupta K, Miller JD, Li JZ, Russell MW, Charbonneau C. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev. 2008;34(3):193–205.CrossRefPubMedGoogle Scholar
  2. 2.
    Linehan WM, Walther MM, Zbar B. The genetic basis of cancer of the kidney. J Urol. 2003;170(6):2163–72.CrossRefPubMedGoogle Scholar
  3. 3.
    Renshaw A. Subclassification of renal cell neoplasms: an update for the practising pathologist. Histopathology. 2002;41(4):283–300.CrossRefPubMedGoogle Scholar
  4. 4.
    Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer discovery. 2011;1(5):391–407.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Spizzo R, Almeida MI, Colombatti A, Calin GA. Long non-coding RNAs and cancer: a new frontier of translational research& quest. Oncogene. 2012;31(43):4577–87.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861–74.CrossRefPubMedGoogle Scholar
  7. 7.
    Wang Y, He L, Du Y, Zhu P, Huang G, Luo J, et al. The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of wnt signaling. Cell Stem Cell. 2015;16(4):413–25.CrossRefPubMedGoogle Scholar
  8. 8.
    Graham LD, Pedersen SK, Brown GS, Ho T, Kassir Z, Moynihan AT, et al. Colorectal neoplasia differentially expressed (CRNDE), a novel gene with elevated expression in colorectal adenomas and adenocarcinomas. Genes & cancer. 2011;2(8):829–40.CrossRefGoogle Scholar
  9. 9.
    Wang Y, Wang Y, Li J, Zhang Y, Yin H, Han B. CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling. Cancer Lett. 2015;367(2):122–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Hajjari M, Khoshnevisan A. Potential long non-coding RNAs to be considered as biomarkers or therapeutic targets in gastric cancer. Front Genet. 2013;4:210.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Wang J, Zhang K, Wang J, Wu X, Liu X, Li B, et al. Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma. Oncotarget. 2015;6(22):18905–20. doi: 10.18632/oncotarget.4305.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Lenburg ME, Liou LS, Gerry NP, Frampton GM, Cohen HT, Christman MF. Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data. BMC Cancer. 2003;3(1):1.CrossRefGoogle Scholar
  13. 13.
    Yusenko MV, Kuiper RP, Boethe T, Ljungberg B, van Kessel AG, Kovacs G. High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas. BMC Cancer. 2009;9(1):152.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Szafron L, Balcerak A, Grzybowska E, Pienkowskagrela B, Felisiakgolabek A, Podgorska A, et al. The novel gene CRNDE encodes a nuclear peptide (CRNDEP) which is overexpressed in highly proliferating tissues. PLoS One. 2015;10(5):e0127475.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Musgrove EA. Cyclins: roles in mitogenic signaling and oncogenic transformation: mini review. Growth Factors. 2006;24(1):13–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Davidson G, Shen J, Huang Y-L, Su Y, Karaulanov E, Bartscherer K, et al. Cell cycle control of wnt receptor activation. Dev Cell. 2009;17(6):788–99.CrossRefPubMedGoogle Scholar
  17. 17.
    Moon RT, Bowerman B, Boutros M, Perrimon N. The promise and perils of Wnt signaling through β-catenin. Science. 2002;296(5573):1644–6.CrossRefPubMedGoogle Scholar
  18. 18.
    Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464(7291):1071–6.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Yang F, Zhang L, Huo X, Yuan Jh, D X, Sx Y, et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology. 2011;54(5):1679–89.CrossRefPubMedGoogle Scholar
  20. 20.
    Gutschner T, Hämmerle M, Eißmann M, Hsu J, Kim Y, Hung G, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013;73(3):1180–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Xiang J-F, Yin Q-F, Chen T, Zhang Y, Zhang X-O, Wu Z, et al. Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus. Cell Res. 2014;24(5):513–31.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Prensner JR, Iyer MK, Sahu A, Asangani IA, Cao Q, Patel L, et al. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nat Genet. 2013;45(11):1392–8.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Qureshi IA, Mehler MF. Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat Rev Neurosci. 2012;13(8):528–41.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Korkaya H, Paulson A, Charafe-Jauffret E, Ginestier C, Brown M, Dutcher J, et al. Regulation of mammary stem/progenitor cells by PTEN/Akt/β-catenin signaling. PLoS Biol. 2009;7(6):e1000121.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Moon RT, Kohn AD, De Ferrari GV, Kaykas AWNT. β-catenin signalling: diseases and therapies. Nat Rev Genet. 2004;5(9):691–701.CrossRefPubMedGoogle Scholar
  26. 26.
    Huber O, Korn R, McLaughlin J, Ohsugi M, Herrmann BG, Kemler R. Nuclear localization of β-catenin by interaction with transcription factor LEF-1. Mech Dev. 1996;59(1):3–10.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2016

Authors and Affiliations

  • Kun Shao
    • 1
  • Tianming Shi
    • 1
  • Yang Yang
    • 1
  • Xianghui Wang
    • 1
  • Da Xu
    • 1
  • Peijun Zhou
    • 1
  1. 1.Department of Urology, Ruijin HospitalShanghai Jiao Tong University School of MedicineShanghaiChina

Personalised recommendations